Literature DB >> 8214059

A minimal model for human whole body cholesterol metabolism.

R E Ostlund1.   

Abstract

Important work by others has shown that human whole body cholesterol metabolism can be described by a three-compartment model computed from plasma cholesterol specific activity after an intravenous infusion of labeled cholesterol. However, some parameters of that model cannot be estimated precisely [coefficient of variation (CV) 15-19% after 40 wk of follow-up], making its use in routine clinical investigation difficult. On the other hand, a simpler two-compartment model can be calculated with excellent precision from only 10 wk of data (CV 2-8%), but its parameters are inaccurate (for example, the size of the central pool is overestimated by 20%, and the rate constant for fractional excretion of cholesterol from the body is underestimated by 15%). Thus both three-compartment and two-compartment models of cholesterol turnover have important limitations. An alternative is provided by a minimal model that takes advantage of the increased precision expected in the solution of models with fewer parameters. A three-compartment structure is used, but only four (rather than 6 or more) parameters are calculated: the mass of the rapidly mixing central cholesterol compartment, the fractional rate of cholesterol elimination from the body, and the average forward and reverse rate constants for cholesterol transfer between the rapid compartment and both slower compartments. Each of these parameters can be determined unambiguously (without the need to use a minimum or maximum estimate), accurately (mean values within 2% of theory), and with precision (CV 3-13%).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8214059     DOI: 10.1152/ajpendo.1993.265.3.E513

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  5 in total

1.  A physiologically based in silico kinetic model predicting plasma cholesterol concentrations in humans.

Authors:  Niek C A van de Pas; Ruud A Woutersen; Ben van Ommen; Ivonne M C M Rietjens; Albert A de Graaf
Journal:  J Lipid Res       Date:  2012-09-29       Impact factor: 5.922

2.  Lipoprotein kinetics in the metabolic syndrome: pathophysiological and therapeutic lessons from stable isotope studies.

Authors:  Dick C Chan; P Hugh R Barrett; Gerald F Watts
Journal:  Clin Biochem Rev       Date:  2004-02

3.  Endogenous Cholesterol Excretion Is Negatively Associated With Carotid Intima-Media Thickness in Humans.

Authors:  Xiaobo Lin; Susan B Racette; Lina Ma; Michael Wallendorf; Victor G Dávila-Román; Richard E Ostlund
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-10-05       Impact factor: 8.311

4.  4beta-hydroxycholesterol as an endogenous marker for CYP3A4/5 activity. Stability and half-life of elimination after induction with rifampicin.

Authors:  Ulf Diczfalusy; Kajsa P Kanebratt; Eva Bredberg; Tommy B Andersson; Ylva Böttiger; Leif Bertilsson
Journal:  Br J Clin Pharmacol       Date:  2008-11-06       Impact factor: 4.335

5.  miR-206 controls LXRα expression and promotes LXR-mediated cholesterol efflux in macrophages.

Authors:  Manjula Vinod; Indumathi Chennamsetty; Sophie Colin; Loic Belloy; Federica De Paoli; Helmut Schaider; Wolfgang F Graier; Saša Frank; Dagmar Kratky; Bart Staels; Giulia Chinetti-Gbaguidi; Gerhard M Kostner
Journal:  Biochim Biophys Acta       Date:  2014-03-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.